1. Home
  2. QIPT vs GANX Comparison

QIPT vs GANX Comparison

Compare QIPT & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quipt Home Medical Corp.

QIPT

Quipt Home Medical Corp.

HOLD

Current Price

$3.58

Market Cap

157.2M

Sector

N/A

ML Signal

HOLD

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$1.81

Market Cap

159.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QIPT
GANX
Founded
1993
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.2M
159.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
QIPT
GANX
Price
$3.58
$1.81
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$3.83
$8.00
AVG Volume (30 Days)
438.2K
651.9K
Earning Date
02-09-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$264,974,000.00
N/A
Revenue This Year
$28.30
N/A
Revenue Next Year
$1.79
N/A
P/E Ratio
N/A
N/A
Revenue Growth
8.28
N/A
52 Week Low
$1.35
$1.41
52 Week High
$3.61
$4.34

Technical Indicators

Market Signals
Indicator
QIPT
GANX
Relative Strength Index (RSI) 71.93 40.89
Support Level $3.55 $1.67
Resistance Level $3.54 $1.86
Average True Range (ATR) 0.02 0.13
MACD -0.02 0.04
Stochastic Oscillator 87.50 46.15

Price Performance

Historical Comparison
QIPT
GANX

About QIPT Quipt Home Medical Corp.

Quipt Home Medical Corp is a provider of durable medical equipment (DME) and home medical equipment (HME) in the United States. The Company specializes in delivering in-home treatments for the management of chronic conditions, with a primary focus on respiratory diseases, and supports patients with heart and pulmonary diseases, sleep apnea, reduced mobility, and other chronic health challenges. Its products and services include Sleep Apnea and PAP treatment, home medical equipment, home ventilation, and custom mobility solutions. The Company operates in a single business segment, comprising the sale and rental of medical equipment and related devices, and serves patients across 27 states in the United States.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: